Description
This exploratory analysis, which requires confirmation in future studies, suggests that the effect of prasinezumab in slowing motor progression in PD may be sustained long-term.
| Date made available | 2024 |
|---|---|
| Publisher | figshare |
Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
- Gennaro Pagano (Creator)
- Annabelle Monnet (Creator)
- Adriana Reyes (Creator)
- Benjamin Ribba (Creator)
- Hanno Svoboda (Creator)
- Thomas Kustermann (Creator)
- Tatyana Simuni (Creator)
- Ron Postuma (Creator)
- Nicola Pavese (Creator)
- Fabrizio Stocchi (Creator)
- Kathrin Brockmann (Creator)
- Krzysztof Smigorski (Creator)
- Valentina Gerbaldo (Creator)
- Paulo Fontoura (Creator)
- Rachelle S. Doody (Creator)
- Geoffrey A. Kerchner (Creator)
- Patrik Brundin (Creator)
- Kenneth Marek (Creator)
- Azad Bonni (Creator)
- T. Nikolcheva (Creator)
Dataset